Precision Health Clinical Trials

Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma

Conditions:   Barrett Esophagus;   Esophageal Cancer
Intervention:  
Sponsors:   Ochsner Health System;   The University of Queensland
Recruiting

Impact of Traditional Chinese Medicine on the Gut Microbiota-dependent Trimethylamine N-oxide

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Compound Panax Notoginseng Granule;   Drug: Placebo Granule
Sponsors:   Guangdong Provincial Hospital of Traditional Chinese Medicine;   Beijing Genomics Institute
Recruiting

Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.

Condition:   Acne Vulgaris
Intervention:   Diagnostic Test: blood sample
Sponsor:   Assiut University
Not yet recruiting

New Genes in the Carcinogenesis of Colorectal Cancer

Condition:   Colo-rectal Cancer
Intervention:   Diagnostic Test: blood sample
Sponsor:   Assiut University
Not yet recruiting

Mapping Disease Pathways for Biliary Atresia

Condition:   Biliary Atresia
Intervention:  
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Conditions:   Colorectal Cancer;   Colorectal Cancer Metastatic;   Hepatic Metastases
Intervention:  
Sponsors:   University Health Network, Toronto;   Terry Fox Research Institute;   British Columbia Cancer Agency
Recruiting

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

Condition:   Non-small Cell Lung Cancer
Intervention:   Drug: pembrolizumab
Sponsors:   Sichuan University;   Geneplus-Beijing Co. Ltd.
Recruiting

the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment

Condition:   Triple Negative Breast Cancer
Interventions:   Drug: Vinorelbine Tartrate;   Drug: Capecitabine 500 MG
Sponsor:   Mario Negri Institute for Pharmacological Research
Recruiting

Action of the Vidaza on the Atrial Fibrillation

Conditions:   Atrial Fibrillation;   Acute Leukemia
Intervention:   Other: Effect of Vidaza treatment
Sponsor:   Hospices Civils de Lyon
Recruiting

MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

Condition:   Heart Diseases
Intervention:   Other: Receive genetic risk information
Sponsor:   Scripps Translational Science Institute
Recruiting

Pages